High HDL cholesterol isn't the cardiovascular shield we thought it was

The assumption that elevated HDL cholesterol automatically confers cardiovascular protection is facing serious scrutiny in contemporary medical literature. Despite decades of marketing as "good cholesterol", the physiological reality proves considerably more intricate: high HDL-C alone fails to guarantee reduced cardiac event risk, and in some metabolic contexts may even correlate with underlying endothelial dysfunction or undetected systemic inflammation. Peter Attia's analysis for The Drive examines how factors including HDL particle composition, functional capacity for reverse cholesterol transport, and individual metabolic context determine actual cardiovascular benefit far more meaningfully than the raw HDL-C number. For longevity-focused readers, this signals a critical recalibration: moving away from optimizing a single lab value toward a more sophisticated framework that integrates inflammatory markers, endothelial function, and lipoprotein quality as an integrated system.